TANG CAPITAL MANAGEMENT LLC Holdings

TANG CAPITAL MANAGEMENT LLC is an investment fund managing more than 815.42M US dollars. The largest holdings include AnaptysBio, Biohaven Ltd. and bluebird bio. In Q3 2022 the fund bought assets of total value of 228.38M US dollars and sold assets of total value of 85.66M US dollars.

$815.42M

portfolio value

+10.56%

quarter

-39.09%

1 year

-84.36%

3 years

-203.79%

5 years

TANG CAPITAL MANAGEMENT LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2016	13089000	10941000
Q3 2016	29243000	10703000
Q1 2017	95553000	601000
Q4 2017	305058000	4225000
Q3 2018	-6269000	147609000
Q4 2018	-64099000	84148000
Q1 2019	17686000	81000000
Q2 2019	235484000	379000
Q3 2019	15227000	8498000
Q4 2019	146859000	14800000
Q1 2020	91779000	111611000
Q2 2020	110961000	40391000
Q3 2020	-408147000	77399000
Q4 2020	172867000	175398000
Q1 2021	12658000	59921000
Q2 2021	157869000	3841000
Q4 2021	101777000	50045000
Q1 2022	224540000	165548000
Q2 2022	249110000	11570000
Q3 2022	228382000	85659000

TANG CAPITAL MANAGEMENT LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology AnaptysBio, Inc. Portfolio share: 8.22% Portfolio value: 67.05M Avg. open price: $16.38 Current price: $28.65 P/L: +74.87% Bought +3.95% shares Q3 2020	share	8.22%	67.05M	$16.38	$28.65	+74.87%	Bought +3.95% shares Q3 2020
Biotechnology Biohaven Ltd. Portfolio share: 5.19% Portfolio value: 42.32M Avg. open price: N/A Current price: $16.32 P/L: N/A N/A Q2 2022	share	5.19%	42.32M	N/A	$16.32	N/A	N/A Q2 2022
Biotechnology bluebird bio, Inc. Portfolio share: 4.92% Portfolio value: 40.10M Avg. open price: $4.79 Current price: $8.01 P/L: +67.33% Bought +7.19% shares Q3 2022	share	4.92%	40.10M	$4.79	$8.01	+67.33%	Bought +7.19% shares Q3 2022
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 4.39% Portfolio value: 35.77M Avg. open price: $16.81 Current price: $16.74 P/L: -0.44% Bought +0.26% shares Q3 2022	share	4.39%	35.77M	$16.81	$16.74	-0.44%	Bought +0.26% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 4.07% Portfolio value: 33.20M Avg. open price: $8.16 Current price: $11.09 P/L: +35.88% Sold -27.77% shares Q3 2022	share	4.07%	33.20M	$8.16	$11.09	+35.88%	Sold -27.77% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 3.65% Portfolio value: 29.77M Avg. open price: N/A Current price: $54.25 P/L: N/A Sold -8.57% shares Q3 2022	share	3.65%	29.77M	N/A	$54.25	N/A	Sold -8.57% shares Q3 2022
Biotechnology Heron Therapeutics, Inc. Portfolio share: 3.54% Portfolio value: 28.86M Avg. open price: $9.36 Current price: $2.54 P/L: -72.85% Bought +83.87% shares Q3 2022	share	3.54%	28.86M	$9.36	$2.54	-72.85%	Bought +83.87% shares Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 3.27% Portfolio value: 26.69M Avg. open price: $549.02 Current price: $405.79 P/L: -26.09% Bought +8.47% shares Q3 2022	share	3.27%	26.69M	$549.02	$405.79	-26.09%	Bought +8.47% shares Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 3.20% Portfolio value: 26.11M Avg. open price: $14.74 Current price: $5.17 P/L: -64.93% Bought +177.66% shares Q2 2022	share	3.20%	26.11M	$14.74	$5.17	-64.93%	Bought +177.66% shares Q2 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 2.61% Portfolio value: 21.28M Avg. open price: $23.53 Current price: $22.7 P/L: -3.51% Bought +57.07% shares Q3 2022	share	2.61%	21.28M	$23.53	$22.7	-3.51%	Bought +57.07% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 2.48% Portfolio value: 20.20M Avg. open price: N/A Current price: $19.03 P/L: N/A Sold -50.00% shares Q1 2022	share	2.48%	20.20M	N/A	$19.03	N/A	Sold -50.00% shares Q1 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.45% Portfolio value: 20.01M Avg. open price: N/A Current price: $226.4 P/L: N/A N/A Q3 2022	share	2.45%	20.01M	N/A	$226.4	N/A	N/A Q3 2022
Biotechnology Immunocore Holdings plc Portfolio share: 2.33% Portfolio value: 19.03M Avg. open price: $37.31 Current price: $58.07 P/L: +55.64% Bought +5.19% shares Q3 2022	share	2.33%	19.03M	$37.31	$58.07	+55.64%	Bought +5.19% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 2.22% Portfolio value: 18.10M Avg. open price: $11.57 Current price: $26.84 P/L: +131.98% Bought +120.73% shares Q3 2022	share	2.22%	18.10M	$11.57	$26.84	+131.98%	Bought +120.73% shares Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 2.19% Portfolio value: 17.85M Avg. open price: $25.72 Current price: $20.04 P/L: -22.09% Bought +4.17% shares Q4 2021	share	2.19%	17.85M	$25.72	$20.04	-22.09%	Bought +4.17% shares Q4 2021
Biotechnology BioAtla, Inc. Portfolio share: 1.86% Portfolio value: 15.14M Avg. open price: $8.98 Current price: $10.52 P/L: +17.18% Sold -41.68% shares Q3 2022	share	1.86%	15.14M	$8.98	$10.52	+17.18%	Sold -41.68% shares Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 1.85% Portfolio value: 15.12M Avg. open price: N/A Current price: $11.58 P/L: N/A N/A Q2 2022	share	1.85%	15.12M	N/A	$11.58	N/A	N/A Q2 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 1.82% Portfolio value: 14.80M Avg. open price: N/A Current price: $4.45 P/L: N/A N/A Q2 2022	share	1.82%	14.80M	N/A	$4.45	N/A	N/A Q2 2022
Biotechnology BeiGene, Ltd. Portfolio share: 1.74% Portfolio value: 14.15M Avg. open price: N/A Current price: $188.71 P/L: N/A N/A Q3 2022	share	1.74%	14.15M	N/A	$188.71	N/A	N/A Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 1.68% Portfolio value: 13.73M Avg. open price: $48.77 Current price: $60.91 P/L: +24.89% Bought +3.33% shares Q3 2022	share	1.68%	13.73M	$48.77	$60.91	+24.89%	Bought +3.33% shares Q3 2022
Internet Content & Information Twitter, Inc. (delisted) Portfolio share: 1.61% Portfolio value: 13.15M Avg. open price: N/A Current price: $53.7 P/L: N/A N/A Q3 2022	share	1.61%	13.15M	N/A	$53.7	N/A	N/A Q3 2022
Biotechnology Veru Inc. Portfolio share: 1.55% Portfolio value: 12.67M Avg. open price: N/A Current price: $5.82 P/L: N/A Sold -76.24% shares Q3 2022	share	1.55%	12.67M	N/A	$5.82	N/A	Sold -76.24% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 1.32% Portfolio value: 10.77M Avg. open price: N/A Current price: $19.89 P/L: N/A N/A Q3 2022	share	1.32%	10.77M	N/A	$19.89	N/A	N/A Q3 2022
Biotechnology Galapagos NV Portfolio share: 1.18% Portfolio value: 9.59M Avg. open price: N/A Current price: $38.92 P/L: N/A Sold -10.02% shares Q3 2022	share	1.18%	9.59M	N/A	$38.92	N/A	Sold -10.02% shares Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 1.16% Portfolio value: 9.45M Avg. open price: $19.46 Current price: $18.33 P/L: -5.81% Bought +350.00% shares Q3 2022	share	1.16%	9.45M	$19.46	$18.33	-5.81%	Bought +350.00% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 1.08% Portfolio value: 8.84M Avg. open price: N/A Current price: $38.98 P/L: N/A N/A Q1 2022	share	1.08%	8.84M	N/A	$38.98	N/A	N/A Q1 2022
Biotechnology Nkarta, Inc. Portfolio share: 1.07% Portfolio value: 8.72M Avg. open price: $12.02 Current price: $8.15 P/L: -32.17% Bought +89.39% shares Q3 2022	share	1.07%	8.72M	$12.02	$8.15	-32.17%	Bought +89.39% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 1.01% Portfolio value: 8.22M Avg. open price: N/A Current price: $68.42 P/L: N/A N/A Q3 2022	share	1.01%	8.22M	N/A	$68.42	N/A	N/A Q3 2022
Biotechnology Allakos Inc. Portfolio share: 0.99% Portfolio value: 8.09M Avg. open price: N/A Current price: $8.14 P/L: N/A N/A Q4 2021	share	0.99%	8.09M	N/A	$8.14	N/A	N/A Q4 2021
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 0.98% Portfolio value: 8.01M Avg. open price: N/A Current price: $21.45 P/L: N/A N/A Q3 2022	share	0.98%	8.01M	N/A	$21.45	N/A	N/A Q3 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.98% Portfolio value: 8M Avg. open price: $12.82 Current price: $11.61 P/L: -9.44% Bought +2.43% shares Q3 2022	share	0.98%	8M	$12.82	$11.61	-9.44%	Bought +2.43% shares Q3 2022
Biotechnology Revance Therapeutics, Inc. Portfolio share: 0.95% Portfolio value: 7.76M Avg. open price: N/A Current price: $21.1 P/L: N/A N/A Q3 2022	share	0.95%	7.76M	N/A	$21.1	N/A	N/A Q3 2022
Biotechnology Kiniksa Pharmaceuticals, Ltd. Portfolio share: 0.94% Portfolio value: 7.70M Avg. open price: $9.94 Current price: $15.73 P/L: +58.25% Bought +20.00% shares Q2 2022	share	0.94%	7.70M	$9.94	$15.73	+58.25%	Bought +20.00% shares Q2 2022
Biotechnology Coherus BioSciences, Inc. Portfolio share: 0.88% Portfolio value: 7.20M Avg. open price: $16.88 Current price: $6.74 P/L: -60.07% Bought +15.38% shares Q1 2022	share	0.88%	7.20M	$16.88	$6.74	-60.07%	Bought +15.38% shares Q1 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.88% Portfolio value: 7.17M Avg. open price: N/A Current price: $5.43 P/L: N/A N/A Q4 2021	share	0.88%	7.17M	N/A	$5.43	N/A	N/A Q4 2021
Biotechnology Enanta Pharmaceuticals, Inc. Portfolio share: 0.88% Portfolio value: 7.14M Avg. open price: $71.18 Current price: $43.06 P/L: -39.51% Bought +37.70% shares Q2 2022	share	0.88%	7.14M	$71.18	$43.06	-39.51%	Bought +37.70% shares Q2 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.84% Portfolio value: 6.82M Avg. open price: N/A Current price: $119.41 P/L: N/A N/A Q3 2022	share	0.84%	6.82M	N/A	$119.41	N/A	N/A Q3 2022
Biotechnology TCR2 Therapeutics Inc. Portfolio share: 0.83% Portfolio value: 6.73M Avg. open price: $2.78 Current price: $1.37 P/L: -50.70% Bought +2.75% shares Q3 2022	share	0.83%	6.73M	$2.78	$1.37	-50.70%	Bought +2.75% shares Q3 2022
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.82% Portfolio value: 6.72M Avg. open price: N/A Current price: $4.76 P/L: N/A N/A Q3 2022	share	0.82%	6.72M	N/A	$4.76	N/A	N/A Q3 2022
Biotechnology BridgeBio Pharma, Inc. Portfolio share: 0.71% Portfolio value: 5.81M Avg. open price: N/A Current price: $9.17 P/L: N/A N/A Q3 2022	share	0.71%	5.81M	N/A	$9.17	N/A	N/A Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 0.64% Portfolio value: 5.23M Avg. open price: N/A Current price: $33.96 P/L: N/A N/A Q1 2022	share	0.64%	5.23M	N/A	$33.96	N/A	N/A Q1 2022
Biotechnology CytomX Therapeutics, Inc. Portfolio share: 0.62% Portfolio value: 5.07M Avg. open price: $1.83 Current price: $1.71 P/L: -6.56% Bought +231.86% shares Q3 2022	share	0.62%	5.07M	$1.83	$1.71	-6.56%	Bought +231.86% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.55% Portfolio value: 4.50M Avg. open price: N/A Current price: $36.66 P/L: N/A N/A Q3 2022	share	0.55%	4.50M	N/A	$36.66	N/A	N/A Q3 2022
Biotechnology Genfit S.A. Portfolio share: 0.54% Portfolio value: 4.37M Avg. open price: $4.53 Current price: $3.67 P/L: -18.95% Sold -5.07% shares Q3 2022	share	0.54%	4.37M	$4.53	$3.67	-18.95%	Sold -5.07% shares Q3 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.54% Portfolio value: 4.36M Avg. open price: N/A Current price: $15.36 P/L: N/A N/A Q1 2022	share	0.54%	4.36M	N/A	$15.36	N/A	N/A Q1 2022
Biotechnology BioNTech SE Portfolio share: 0.50% Portfolio value: 4.04M Avg. open price: N/A Current price: $166.71 P/L: N/A Sold -25.00% shares Q3 2022	share	0.50%	4.04M	N/A	$166.71	N/A	Sold -25.00% shares Q3 2022
Internet Retail Alibaba Group Holding Limited Portfolio share: 0.49% Portfolio value: 4M Avg. open price: N/A Current price: $90.52 P/L: N/A N/A Q2 2022	share	0.49%	4M	N/A	$90.52	N/A	N/A Q2 2022
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.48% Portfolio value: 3.88M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2022	share	0.48%	3.88M	N/A	$9.96	N/A	N/A Q3 2022
Biotechnology Aldeyra Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 3.73M Avg. open price: N/A Current price: $6.46 P/L: N/A N/A Q3 2022	share	0.46%	3.73M	N/A	$6.46	N/A	N/A Q3 2022
Biotechnology Fortress Biotech, Inc. Portfolio share: 0.44% Portfolio value: 3.60M Avg. open price: $1.12 Current price: $0.7 P/L: -37.11% Bought +25.48% shares Q3 2022	share	0.44%	3.60M	$1.12	$0.7	-37.11%	Bought +25.48% shares Q3 2022
Biotechnology Graphite Bio, Inc. Portfolio share: 0.43% Portfolio value: 3.48M Avg. open price: N/A Current price: $3.59 P/L: N/A N/A Q2 2022	share	0.43%	3.48M	N/A	$3.59	N/A	N/A Q2 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 0.42% Portfolio value: 3.42M Avg. open price: N/A Current price: $24.25 P/L: N/A N/A Q3 2022	share	0.42%	3.42M	N/A	$24.25	N/A	N/A Q3 2022
Biotechnology ASLAN Pharmaceuticals Limited Portfolio share: 0.42% Portfolio value: 3.38M Avg. open price: $1.15 Current price: $0.53 P/L: -53.67% Bought +1.80% shares Q3 2022	share	0.42%	3.38M	$1.15	$0.53	-53.67%	Bought +1.80% shares Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 3.35M Avg. open price: N/A Current price: $7.49 P/L: N/A N/A Q3 2022	share	0.41%	3.35M	N/A	$7.49	N/A	N/A Q3 2022
Biotechnology aTyr Pharma, Inc. Portfolio share: 0.41% Portfolio value: 3.34M Avg. open price: $55.16 Current price: $2.29 P/L: -95.85% N/A Q3 2021	share	0.41%	3.34M	$55.16	$2.29	-95.85%	N/A Q3 2021
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.40% Portfolio value: 3.26M Avg. open price: N/A Current price: $52.11 P/L: N/A N/A Q3 2022	share	0.40%	3.26M	N/A	$52.11	N/A	N/A Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.40% Portfolio value: 3.26M Avg. open price: $55 Current price: $50.99 P/L: -7.29% Bought +60.00% shares Q3 2022	share	0.40%	3.26M	$55	$50.99	-7.29%	Bought +60.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic ANI Pharmaceuticals, Inc. Portfolio share: 0.39% Portfolio value: 3.21M Avg. open price: N/A Current price: $37.98 P/L: N/A Sold -66.67% shares Q1 2022	share	0.39%	3.21M	N/A	$37.98	N/A	Sold -66.67% shares Q1 2022
Drug Manufacturers—Specialty & Generic Eagle Pharmaceuticals, Inc. Portfolio share: 0.39% Portfolio value: 3.14M Avg. open price: N/A Current price: $33.96 P/L: N/A N/A Q3 2022	share	0.39%	3.14M	N/A	$33.96	N/A	N/A Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.38% Portfolio value: 3.12M Avg. open price: N/A Current price: $77.29 P/L: N/A N/A Q3 2022	share	0.38%	3.12M	N/A	$77.29	N/A	N/A Q3 2022
Biotechnology Clene Inc. Portfolio share: 0.38% Portfolio value: 3.08M Avg. open price: N/A Current price: $1.09 P/L: N/A N/A Q3 2022	share	0.38%	3.08M	N/A	$1.09	N/A	N/A Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.37% Portfolio value: 2.99M Avg. open price: N/A Current price: $9.29 P/L: N/A N/A Q3 2022	share	0.37%	2.99M	N/A	$9.29	N/A	N/A Q3 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.34% Portfolio value: 2.78M Avg. open price: $2.38 Current price: $1.29 P/L: -45.80% Bought +2.36% shares Q3 2022	share	0.34%	2.78M	$2.38	$1.29	-45.80%	Bought +2.36% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 0.32% Portfolio value: 2.63M Avg. open price: N/A Current price: $50.19 P/L: N/A N/A Q3 2022	share	0.32%	2.63M	N/A	$50.19	N/A	N/A Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.32% Portfolio value: 2.58M Avg. open price: N/A Current price: $51.99 P/L: N/A N/A Q2 2022	share	0.32%	2.58M	N/A	$51.99	N/A	N/A Q2 2022
Biotechnology Vanda Pharmaceuticals Inc. Portfolio share: 0.31% Portfolio value: 2.53M Avg. open price: N/A Current price: $10.61 P/L: N/A N/A Q1 2022	share	0.31%	2.53M	N/A	$10.61	N/A	N/A Q1 2022
Biotechnology ADMA Biologics, Inc. Portfolio share: 0.30% Portfolio value: 2.41M Avg. open price: N/A Current price: $3.25 P/L: N/A N/A Q3 2022	share	0.30%	2.41M	N/A	$3.25	N/A	N/A Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.29% Portfolio value: 2.38M Avg. open price: N/A Current price: $44.37 P/L: N/A N/A Q3 2022	share	0.29%	2.38M	N/A	$44.37	N/A	N/A Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 0.27% Portfolio value: 2.16M Avg. open price: N/A Current price: $5.87 P/L: N/A N/A Q3 2022	share	0.27%	2.16M	N/A	$5.87	N/A	N/A Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 0.26% Portfolio value: 2.11M Avg. open price: N/A Current price: $10.02 P/L: N/A Sold -66.67% shares Q3 2022	share	0.26%	2.11M	N/A	$10.02	N/A	Sold -66.67% shares Q3 2022
Biotechnology MoonLake Immunotherapeutics Portfolio share: 0.25% Portfolio value: 2.01M Avg. open price: N/A Current price: $10.07 P/L: N/A Sold -18.80% shares Q3 2022	share	0.25%	2.01M	N/A	$10.07	N/A	Sold -18.80% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 1.84M Avg. open price: $1.21 Current price: $0.97 P/L: -20.12% Bought +8.17% shares Q3 2022	share	0.23%	1.84M	$1.21	$0.97	-20.12%	Bought +8.17% shares Q3 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 0.21% Portfolio value: 1.74M Avg. open price: N/A Current price: $5.61 P/L: N/A N/A Q3 2022	share	0.21%	1.74M	N/A	$5.61	N/A	N/A Q3 2022
Biotechnology TScan Therapeutics, Inc. Portfolio share: 0.21% Portfolio value: 1.70M Avg. open price: $2.8 Current price: $2.21 P/L: -21.07% Sold -25.39% shares Q3 2022	share	0.21%	1.70M	$2.8	$2.21	-21.07%	Sold -25.39% shares Q3 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 0.18% Portfolio value: 1.50M Avg. open price: N/A Current price: $4.91 P/L: N/A N/A Q3 2022	share	0.18%	1.50M	N/A	$4.91	N/A	N/A Q3 2022
Leisure Inspirato Incorporated Portfolio share: 0.18% Portfolio value: 1.44M Avg. open price: $9.94 Current price: $1.82 P/L: -81.69% Sold -80.60% shares Q3 2022	share	0.18%	1.44M	$9.94	$1.82	-81.69%	Sold -80.60% shares Q3 2022
Biotechnology Vincerx Pharma, Inc. Portfolio share: 0.17% Portfolio value: 1.42M Avg. open price: $19.3 Current price: $0.7 P/L: -96.37% Bought +106.13% shares Q2 2021	share	0.17%	1.42M	$19.3	$0.7	-96.37%	Bought +106.13% shares Q2 2021
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 1.39M Avg. open price: N/A Current price: $92.75 P/L: N/A N/A Q3 2022	share	0.17%	1.39M	N/A	$92.75	N/A	N/A Q3 2022
Biotechnology Nektar Therapeutics Portfolio share: 0.17% Portfolio value: 1.37M Avg. open price: N/A Current price: $2.97 P/L: N/A N/A Q1 2022	share	0.17%	1.37M	N/A	$2.97	N/A	N/A Q1 2022
Biotechnology Equillium, Inc. Portfolio share: 0.16% Portfolio value: 1.33M Avg. open price: N/A Current price: $1.65 P/L: N/A N/A Q4 2020	share	0.16%	1.33M	N/A	$1.65	N/A	N/A Q4 2020
Electrical Equipment & Parts Tritium DCFC Limited Portfolio share: 0.16% Portfolio value: 1.27M Avg. open price: $10.04 Current price: $1.27 P/L: -87.35% Sold -20.00% shares Q3 2022	share	0.16%	1.27M	$10.04	$1.27	-87.35%	Sold -20.00% shares Q3 2022
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.13% Portfolio value: 1.1M Avg. open price: N/A Current price: $0.52 P/L: N/A Sold -50.00% shares Q1 2022	share	0.13%	1.1M	N/A	$0.52	N/A	Sold -50.00% shares Q1 2022
Drug Manufacturers—Specialty & Generic Dynavax Technologies Corporation Portfolio share: 0.13% Portfolio value: 1.04M Avg. open price: N/A Current price: $12.3 P/L: N/A N/A Q3 2022	share	0.13%	1.04M	N/A	$12.3	N/A	N/A Q3 2022
Biotechnology Orchard Therapeutics plc Portfolio share: 0.12% Portfolio value: 1M Avg. open price: N/A Current price: $0.45 P/L: N/A N/A Q2 2022	share	0.12%	1M	N/A	$0.45	N/A	N/A Q2 2022
Biotechnology Alector, Inc. Portfolio share: 0.12% Portfolio value: 946K Avg. open price: N/A Current price: $8.68 P/L: N/A N/A Q1 2022	share	0.12%	946K	N/A	$8.68	N/A	N/A Q1 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.11% Portfolio value: 925K Avg. open price: $3.07 Current price: $1.1 P/L: -64.17% Bought +267.75% shares Q3 2022	share	0.11%	925K	$3.07	$1.1	-64.17%	Bought +267.75% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 0.11% Portfolio value: 890K Avg. open price: N/A Current price: $39.53 P/L: N/A N/A Q3 2022	share	0.11%	890K	N/A	$39.53	N/A	N/A Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.11% Portfolio value: 880K Avg. open price: N/A Current price: $2.79 P/L: N/A N/A Q2 2022	share	0.11%	880K	N/A	$2.79	N/A	N/A Q2 2022
Biotechnology Metacrine, Inc. Portfolio share: 0.10% Portfolio value: 833K Avg. open price: N/A Current price: $0.41 P/L: N/A N/A Q3 2022	share	0.10%	833K	N/A	$0.41	N/A	N/A Q3 2022
Biotechnology Homology Medicines, Inc. Portfolio share: 0.04% Portfolio value: 346K Avg. open price: N/A Current price: $1.47 P/L: N/A N/A Q1 2022	share	0.04%	346K	N/A	$1.47	N/A	N/A Q1 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.04% Portfolio value: 296K Avg. open price: N/A Current price: $1.4 P/L: N/A N/A Q2 2022	share	0.04%	296K	N/A	$1.4	N/A	N/A Q2 2022
Drug Manufacturers—Specialty & Generic Evolus, Inc. Portfolio share: 0.04% Portfolio value: 294K Avg. open price: $12.17 Current price: $6.98 P/L: -42.65% N/A Q3 2022	share	0.04%	294K	$12.17	$6.98	-42.65%	N/A Q3 2022
Biotechnology Molecular Partners AG Portfolio share: 0.01% Portfolio value: 105K Avg. open price: N/A Current price: $6.82 P/L: N/A N/A Q3 2022	share	0.01%	105K	N/A	$6.82	N/A	N/A Q3 2022
Leisure Inspirato Incorporated Portfolio share: 0.01% Portfolio value: 88K Avg. open price: N/A Current price: $0.11 P/L: N/A Sold -68.80% shares Q3 2022	share	0.01%	88K	N/A	$0.11	N/A	Sold -68.80% shares Q3 2022
Drug Manufacturers—Specialty & Generic AcelRx Pharmaceuticals, Inc. Portfolio share: 0.01% Portfolio value: 81K Avg. open price: N/A Current price: $2.19 P/L: N/A N/A Q3 2022	share	0.01%	81K	N/A	$2.19	N/A	N/A Q3 2022
Biotechnology La Jolla Pharmaceutical Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.69 Current price: $6.22 P/L: -28.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.69	$6.22	-28.40%	Sold -100.00% shares Q3 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.69 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.69	N/A	Sold -100.00% shares Q3 2022
Biotechnology Roivant Sciences Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.18 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.18	N/A	Sold -100.00% shares Q3 2022
Biotechnology Corvus Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $1.64 Current price: $1 P/L: -39.02% Sold -100.00% shares Q3 2022	share	0.00%	0	$1.64	$1	-39.02%	Sold -100.00% shares Q3 2022
Biotechnology Reviva Pharmaceuticals Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.86 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.86	N/A	Sold -100.00% shares Q3 2022

Showing TOP 100 TANG CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of TANG CAPITAL MANAGEMENT LLC?

The biggest position of the TANG CAPITAL MANAGEMENT LLC is AnaptysBio, Inc. (ANAB) with 8.22% portfolio share worth of 67.06M US dollars.

Top 5 TANG CAPITAL MANAGEMENT's holdings represent 26.79% of the portfolio:

AnaptysBio, Inc. (ANAB) – 8.22%
Biohaven Ltd. (BHVN) – 5.19%
bluebird bio, Inc. (BLUE) – 4.92%
Tarsus Pharmaceuticals, Inc. (TARS) – 4.39%
Altimmune, Inc. (ALT) – 4.07%

Who is the portfolio manager of TANG CAPITAL MANAGEMENT LLC?

The portfolio manager of the TANG CAPITAL MANAGEMENT LLC is .

What is the total asset value of the TANG CAPITAL MANAGEMENT LLC portfolio?

TANG CAPITAL MANAGEMENT LLC total asset value (portfolio value) is 815.42M US dollars.

Who is ?

is the portfolio manager of the TANG CAPITAL MANAGEMENT LLC.

What is (TANG CAPITAL MANAGEMENT LLC) fund performance?

TANG CAPITAL MANAGEMENT's quarterly performance is +10.56%, annualy -39.09%. In the past 3 years, the value of 's portfolio has decreased by -84%. In the past 5 years, the value of the portfolio has decreased by -204%.

What is the TANG CAPITAL MANAGEMENT LLC CIK?

TANG CAPITAL MANAGEMENT's Central Index Key is 0001232621 .

TANG CAPITAL MANAGEMENT LLC Holdings

TANG CAPITAL MANAGEMENT LLC portfolio value:

TANG CAPITAL MANAGEMENT LLC quarter portfolio value change:

TANG CAPITAL MANAGEMENT LLC 1 year portfolio value change:

TANG CAPITAL MANAGEMENT LLC 3 years portfolio value change:

TANG CAPITAL MANAGEMENT LLC 5 years portfolio value change: